A detailed history of Franklin Resources Inc transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 22,314 shares of STOK stock, worth $255,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,314
Previous 1,216,200 98.17%
Holding current value
$255,049
Previous $16.4 Million 98.33%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$12.24 - $15.92 $14.6 Million - $19 Million
-1,193,886 Reduced 98.17%
22,314 $274,000
Q2 2024

Aug 14, 2024

BUY
$11.03 - $17.52 $1.74 Million - $2.77 Million
157,900 Added 14.92%
1,216,200 $16.4 Million
Q1 2024

May 13, 2024

BUY
$4.12 - $14.17 $4.36 Million - $15 Million
1,058,300 New
1,058,300 $14.3 Million
Q2 2023

Aug 11, 2023

BUY
$7.93 - $13.82 $100,258 - $174,726
12,643 New
12,643 $134,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $451M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.